Skip to content

Author

Yanmei Chen

We have 2 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer

Key approaches targeting DNA repair deficiency, immune regulation, oncogenic signaling pathways, and antigen-directed therapies are highlighted, and their clinical development and application are discussed.

Hui-Fang Cheng, Yanmei Chen, Pei-Yan Liu et al. · 0 citations
Review Jul 2026

Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.

The historical milestones in ERK1/2 research are outlined, from their discovery and structural characterization to their identification as oncogenic drivers and therapeutic targets, and the potential of ERK1/2-targeted therapies in precision oncology is highlighted.

Zhi-Qi Peng, Yuqi Fu, Yanmei Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.